Re: Placebo responses in device studies

Peter J Goadsby^{1

2}, David W Dodick³, Richard B Lipton⁴

Affiliations

¹ 1 NIHR-Wellcome Trust King's Clinical Research Facility, King's College London, UK.
² 2 University of California, San Francisco, CA, USA.
³ 3 Mayo Clinic, Scottsdale, AZ, USA.
⁴ 4 Albert Einstein College of Medicine, New York, NY, USA.

Comment

Peter J Goadsby et al. Cephalalgia. 2018 Apr.

. 2018 Apr;38(5):1007-1008.

doi: 10.1177/0333102417722498. Epub 2017 Jul 26.

Peter J Goadsby^{1

2}, David W Dodick³, Richard B Lipton⁴

¹ 1 NIHR-Wellcome Trust King's Clinical Research Facility, King's College London, UK.
² 2 University of California, San Francisco, CA, USA.
³ 3 Mayo Clinic, Scottsdale, AZ, USA.
⁴ 4 Albert Einstein College of Medicine, New York, NY, USA.

No abstract available

Comment on

Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial.
Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, Pearlman SH, Fischell RE, Ruppel PL, Goadsby PJ. Lipton RB, et al. Lancet Neurol. 2010 Apr;9(4):373-80. doi: 10.1016/S1474-4422(10)70054-5. Epub 2010 Mar 4. Lancet Neurol. 2010. PMID: 20206581 Clinical Trial.